(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BIOTISSUE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

BIOTISSUE

ST13

US500000097588024

Class

5, 10, 42

Filing

97588024

Registration

7872385

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

07/22/2025

Trademark type

Word

Nice classes

5, 10, 42

Filing date

09/12/2022

Registration date

07/22/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/22/2025

Last transaction

07/22/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

07/12/2022

First use in commerce

07/12/2022

Drawing code

4

Owner type

03

Owner location

MIAMI, FL

Examiner

GALLOWAY, JAMILLA ESPY

Law office

N30

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

BIOTISSUE HOLDINGS INC.
BIOTISSUE HOLDINGS INC.

Representatives

Alyssa M. Worsham WILSON SONSINI GOODRICH & ROSATI

Technical classification

Nice Classes

Class 5Class 10Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Therapeutic products in the nature of biologic bandages for the treatment of eye diseases; pharmaceutical preparations for treating diseases and disorders affecting the eye; implants of human tissue for guided tissue regeneration; surgical implants comprised of human tissues; surgical implants grown from stem cells; stem cells for medical purposes; tissue-regenerative medical preparations; transplantshuman tissues for transplant purposes

Class 10

surgical implants comprised of naturalnon-living materials for use in guided tissue regeneration; artificial replacement materials for human tissuesynthetic collagen based scaffolding materials; guided tissue regeneration materials in the nature of naturalnon-living bone grafts; implantable surgical textile material to encourage the growth of tissue; implants comprising naturalnon-living materials for guided tissue regeneration; implant materials in the nature of implantable naturalnon-living tissues for use in guided tissue regeneration in surgery; implants comprising of naturalnon-living tissue for guided tissue regeneration; surgical naturalnon-living tissue grafts

Class 42

Biologic research; scientific research and development in the field of biologics and regenerative medicine

Publications

History of USPTO decisions and trademark events.

30 publications found

NRCS

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/22/2025

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

07/22/2025

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

06/17/2025

IUAA

USE AMENDMENT ACCEPTED

06/17/2025

DOCK

ASSIGNED TO EXAMINER

05/28/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/29/2024

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

08/22/2024

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

08/22/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/29/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/29/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

07/29/2024

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

06/20/2024

IUAF

USE AMENDMENT FILED

06/20/2024

EAAU

TEAS AMENDMENT OF USE RECEIVED

06/20/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

04/23/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

04/23/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

02/08/2024

GNFR

FINAL REFUSAL E-MAILED

02/08/2024

CNFR

FINAL REFUSAL WRITTEN

02/08/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/22/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/21/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/21/2023

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

09/27/2023

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

09/27/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/28/2023

GNRT

NON-FINAL ACTION E-MAILED

06/28/2023

CNRT

NON-FINAL ACTION WRITTEN

06/28/2023

DOCK

ASSIGNED TO EXAMINER

06/23/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/28/2022

NWAP

NEW APPLICATION ENTERED

09/15/2022

Continuous trademark protection

Get notified about every new filing that threatens BIOTISSUE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.